Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Large Language Models Assist in Tumor MDT [NA]
A clinical trial is recruiting to test the use of large language models to assist multidisciplinary tumor board discussions across multiple …
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors [Phase 3]
Phase 3 clinical trial assessing whether an educational website (Current Together After Cancer, CTAC) improves follow-up care for colorectal…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Shared Decision-Making for Colorectal Cancer Screening in High-Risk First-Degree Relatives Aged 40-49 [NA]
A clinical trial evaluating shared decision-making tools to help high-risk individuals aged 40-49 decide about colorectal cancer screening, …
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Study Comparing the Contribution of G-Eye Combined With CAD-Eye Versus High-definition Colonoscopy With CAD-Eye in the Detection of Colonic Lesions After a Positive Immunological Test in the Context of Organized Colorectal Cancer (BENEFIT)
A completed clinical trial comparing G-Eye with CAD-Eye versus high-definition colonoscopy with CAD-Eye for detecting colonic lesions after …
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS) [Phase 2]
This Phase 2 clinical trial investigates isunakinra alone and in combination with pembrolizumab for metastatic colorectal cancer (MSS) and i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Effectiveness of a Multimodal Outpatient Supervised Physical Activity Program to Improve Tolerance and Efficacy of Chemotherapy in Adults With Breast, Lung and Colon Cancer [NA]
A clinical trial is planned to evaluate a multimodal outpatient supervised physical activity program designed to improve chemotherapy tolera…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: JS212 Combination Therapies in Metastatic Colorectal Cancer [Phase 2]
Phase 2 clinical trial update for JS212 combination therapies in metastatic colorectal cancer; currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Efficacy and Safety of Colorectal Anastomotic Leak Testing [NA]
A clinical trial evaluating the efficacy and safety of colorectal anastomotic leak testing is currently recruiting for patients with colorec…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC) [Phase 1]
A Phase 1 study from Hoffmann-La Roche evaluating targeted therapies in subpopulations of metastatic colorectal cancer; recruitment is ongoi…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Chlorhexidine Gluconate Versus Saline for Flushing the Surgical Area During Colorectal Cancer Surgery [NA]
A clinical trial is evaluating flushing the surgical area with chlorhexidine gluconate versus saline during colorectal cancer surgery to red…
-
CLINICAL_TRIALS other · 2026-03-31Clinical Trial Update: Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2a study of RP-001 in participants with colorectal cancer or pancreatic cancer, with the trial …
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer [Phase 1]
This Clinical Trials Update describes a Phase 1 study of an Fc-engineered anti-CTLA-4 monoclonal antibody by Agenus in patients with advance…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC
An exploratory clinical evaluation using personalized functional profiling to predict drug response in colorectal cancer and pancreatic duct…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Clinical Study of Iparomlimab and Tuvonralimab Combined With Fruquintinib and Heterogeneous Radiotherapy Versus Fruquintinib as Third-Line and Subsequent-Line Treatment for Metastatic Colorectal Cancer [Phase 2]
This is a Phase 2 clinical trial protocol evaluating iparomlimab and tuvonralimab in combination with fruquintinib and heterogeneous radioth…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals [NA]
A trial update describing a Gustave Roussy-led study evaluating body fluids for early cancer detection in high-risk individuals, with a broa…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
A clinical trial update describing the ongoing recruitment and implementation of a comprehensive multilevel virtual oncology program for vet…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of RAS(ON) inhibitors in combination with Ivonescimab is currently recruiting in patients with solid tumors, including non…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: mPATH-Cloud for Colorectal Cancer Screening [NA]
Clinical trial update for the mPATH-Cloud platform in colorectal cancer screening (NCT06441487) shows the study is currently active but not …
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study of VS-6766 and Cetuximab in Patients With Advanced Colorectal Cancer [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial is evaluating the combination of VS-6766 and cetuximab in patients with advanced colorectal cancer. Recr…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008) [Phase 2]
Clinical trial update on a phase 2 evaluation of a co-formulated pembrolizumab and quavonlimab (MK-1308A) versus other treatments in MSI-H/d…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Community Partnership for Telehealth Solutions to Convey Information and Enhance Care [NA]
This ongoing clinical trial, sponsored by the University of Arizona, investigates a community partnership to implement telehealth solutions …
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer [Phase 1]
Phase 1 study to evaluate SAR445877 in combination with FOLFOX6 and bevacizumab as first-line therapy for microsatellite-stable metastatic c…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes ongoing Phase 1/2 studies of the radiopharmaceutical 177Lu-BetaBart. The trial is evaluating its use in…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: ImmunoNutrition and Colorectal Adenocarcinoma Surgery - INCAS Study [NA]
The INCAS trial evaluating immunonutrition in colorectal cancer surgery was terminated. Phase information was not provided.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer [Phase 2]
Phase 2 trial of two dose levels of ONO-4578 with nivolumab, plus mFOLFOX6 and bevacizumab, versus standard of care in PD-L1 positive, non-M…